Clyra Medical Technologies
Clyra Medical Technologies is a healthcare company dedicated to improving lives by developing and commercializing innovative products for wound and skin infection treatment. As a subsidiary of BioLargo, Inc., Clyra focuses on creating safe, effective, and cost-efficient solutions that reduce the need for antibiotics and promote wound healing. Their technology, based on a copper-iodine complex, offers a broad-spectrum antimicrobial effect without known microbial resistance, making it suitable for various healthcare settings.
Clyra Medical Technologies
3802 Spectrum Blvd, Suite 115, Tampa, FL 33612
What We Do
A highly effective, tissue-safe, long-acting wound irrigation solution for acute and chronic wounds and burns, with no need to rinse out throughout the entire procedure. It is 510(k) cleared by the FDA and offers extremely high antimicrobial activity.
Clyra's copper-iodine complex technology for continued gum health and dental hygiene.
An antimicrobial wound hydrogel dressing for the treatment and protection of chronic and acute wounds, post-surgical wounds, burns, abrasions, and skin irritations.
Clyra technology embedded in super absorbent pads and highly absorbent dressings to manage large quantities of wound exudate, blood, and bodily fluids.
Clyra technology can be impregnated in NPWT dressings and used as an irrigation solution with NPWT systems.
Products for the aesthetic market and post-facial procedures, including facial spritz, post-ablation spray, and acne and scar cream.
Irrigation solutions, sprays, and gel for wounds, ear and eye infections, and oral care in veterinary applications.
Key People
Chief Executive Officer
Chairman of the Board
Director
Director
Director
Chief Operating Officer
News & Updates
Clyra's first wound management product has received 510(k) clearance from the FDA, marking a significant milestone in their product development.